Effects of the CDK-inhibitor CYC202 on p38 MAPK, ERK1/2 and c-Myc activities in papillomavirus type 16 E6- and E7-transformed human keratinocytes

Ganka Atanasova, Antonia R. Isaeva, Nikolai Zhelev, Yves Poumay, Vanyo I. Mitev

    Research output: Contribution to journalArticlepeer-review

    6 Citations (Scopus)
    58 Downloads (Pure)

    Abstract

    In the present study, we have investigated the effect of the chemical CDK-inhibitor CYC202 on E6 and E7-transformed keratinocytes, in which the function of the cellular cell cycle inhibitor p21Cip1 is abrogated by the viral genes. The cyto-toxicity and the inhibition of the cell growth were analysed by MTT assay and analysis of DNA synthesis respectively. The effect on some signalling molecules was tested by Western blot analysis. CYC202 effectively inhibited the proliferation of E6 and E7 keratinocytes in a dose-dependent manner. Treatment with CYC202 strongly increased the activity of p38 MAP kinase. Furthermore, it inhibited ERK1/2 at the highest concentration used and had no effect on the activity of JNK1/2. CYC202 also increased the phosphorylation of HSP27 and decreased the phosphorylation and DNA-binding activity of the transcriptional regulator c-Myc, in correlation with the corresponding upstream kinases p38 MAPK and ERK1/2. Our results provide additional data for the anti-proliferative actions and potency of the chemical CDK-inhibitor CYC202.
    Original languageEnglish
    Pages (from-to)999-1005
    Number of pages7
    JournalOncology Reports
    Volume18
    Issue number4
    Publication statusPublished - Oct 2007

    Keywords

    • Keratinocytes
    • HPV16 E6 and E7 genes
    • CYC202
    • MAP kinases

    Fingerprint

    Dive into the research topics of 'Effects of the CDK-inhibitor CYC202 on p38 MAPK, ERK1/2 and c-Myc activities in papillomavirus type 16 E6- and E7-transformed human keratinocytes'. Together they form a unique fingerprint.

    Cite this